Thermo Fisher Scientific acquires Dionex

Editorial Checklist Reviewed

Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that it has successfully completed its acquisition of Dionex Corporation (NASDAQ: DNEX) through a short-form merger.

Pursuant to the terms of the merger, all outstanding Dionex shares (other than those held by Thermo Fisher, Dionex or any wholly owned subsidiary of Dionex, and any shareholders who validly exercised their appraisal rights in connection with the merger) will be exchanged for $118.50 per share in cash.

Source:

Thermo Fisher Scientific

Posted in: Business / Finance | Life Sciences News

Comments (0)

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Thermo Fisher Scientific Inc.. (2019, June 19). Thermo Fisher Scientific acquires Dionex. News-Medical. Retrieved on November 21, 2024 from https://www.news-medical.net/news/20110518/Thermo-Fisher-Scientific-acquires-Dionex.aspx.

  • MLA

    Thermo Fisher Scientific Inc.. "Thermo Fisher Scientific acquires Dionex". News-Medical. 21 November 2024. <https://www.news-medical.net/news/20110518/Thermo-Fisher-Scientific-acquires-Dionex.aspx>.

  • Chicago

    Thermo Fisher Scientific Inc.. "Thermo Fisher Scientific acquires Dionex". News-Medical. https://www.news-medical.net/news/20110518/Thermo-Fisher-Scientific-acquires-Dionex.aspx. (accessed November 21, 2024).

  • Harvard

    Thermo Fisher Scientific Inc.. 2019. Thermo Fisher Scientific acquires Dionex. News-Medical, viewed 21 November 2024, https://www.news-medical.net/news/20110518/Thermo-Fisher-Scientific-acquires-Dionex.aspx.

Suggested Reading

New Thermo Scientific Neoma Multicollector ICP-MS system delivers reliable isotopic data
Thermo Fisher Scientific launches industry-leading, cGMP-compatible CTS Series Laboratory Equipment
Thermo Fisher Scientific collaborates with AstraZeneca and University of Nebraska Medical Center
Thermo Fisher Scientific and Symphogen extend collaboration to boost drug discovery and development
Thermo Fisher Scientific launches two breakthrough imaging filters that take cryo-EM to a new level
Thermo Fisher Scientific acknowledges the winners of 2020 TMT Research Grant Award
Thermo Fisher announces construction of new cGMP plasmid DNA manufacturing facility
New developments at Evosep to make clinical proteomics 100x more robust and 10x faster

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Trending Stories

More Content from Thermo Fisher Scientific Inc.

See all content from Thermo Fisher Scientific Inc.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
Thermo Scientific MAS Omni Infectious Controls launched to assess the performance of serological assays